J Clin Oncol. 2012 Jan 23. [Epub ahead of print]

Classical Clinical Trial Design in Testicular Cancer: Time to Move On.

Nichols CR, Roth B, Kollmannsberger C.

Source

Virginia Mason Medical Center, Seattle, WA.

PMID:: 22271483; [PubMed - as supplied by publisher]

LinkOut - more resources

Full Text Sources

HighWire Press - PDF

Supplemental Content

Related citations

Alternative trial design in amyotrophic lateral sclerosis saves time and patients. [Amyotroph Lateral Scler. 2007]
Alternative trial design in amyotrophic lateral sclerosis saves time and patients.
Groeneveld GJ, Graf M, van der Tweel I, van den Berg LH, Ludolph AC. Amyotroph Lateral Scler. 2007 Oct; 8(5):266-9.
Evaluation of adjuvant psychological therapy in patients with testicular cancer: randomised controlled trial. [BMJ. 1998]
Evaluation of adjuvant psychological therapy in patients with testicular cancer: randomised controlled trial.
Moynihan C, Bliss JM, Davidson J, Burchell L, Horwich A. BMJ. 1998 Feb 7; 316(7129):429-35.
The incidence, prognosis, clinical and histological characteristics, treatment, and outcome of patients with bilateral germ cell testicular cancer in Hungary. [J Cancer Res Clin Oncol. 2003]
The incidence, prognosis, clinical and histological characteristics, treatment, and outcome of patients with bilateral germ cell testicular cancer in Hungary.
Géczi L, Gomez F, Bak M, Bodrogi I. J Cancer Res Clin Oncol. 2003 May; 129(5):309-15. Epub 2003 May 14.
Review Does prolonging the time to testicular cancer surgery impact long-term cancer control: a systematic review of the literature. [Can J Urol. 2006]
Review Does prolonging the time to testicular cancer surgery impact long-term cancer control: a systematic review of the literature.
Bell D, Morash C, Dranitsaris G, Izawa J, Short T, Klotz LH, Fleshner N, Canadian surgical wait times (SWAT) initiative. Can J Urol. 2006 Jun; 13 Suppl 3:30-6.
Review Hematopoietic growth factors and treatment of testicular cancer: biological interactions, routine use and dose-intensive chemotherapy. [Ann Hematol. 1996]
Review Hematopoietic growth factors and treatment of testicular cancer: biological interactions, routine use and dose-intensive chemotherapy.
Bokemeyer C, Kuczyk MA, Köhne H, Einsele H, Kynast B, Schmoll HJ. Ann Hematol. 1996 Jan; 72(1):1-9.

See reviews... See all...

Recent activity

Clear Turn Off Turn On

Classical Clinical Trial Design in Testicular Cancer: Time to Move On.
Classical Clinical Trial Design in Testicular Cancer: Time to Move On.
J Clin Oncol. 2012 Jan 23. [Epub ahead of print]

PubMed
Phase II trial of temsirolimus in patients with metastatic breast cancer.
Phase II trial of temsirolimus in patients with metastatic breast cancer.
Breast Cancer Res Treat. 2012 Jan 13. [Epub ahead of print]

PubMed
Analysis of mannose 6-phosphate uncovering enzyme mutations associated with pers...
Analysis of mannose 6-phosphate uncovering enzyme mutations associated with persistent stuttering.
J Biol Chem. 2011 Nov 18 ;286(46):39786-93. Epub 2011 Sep 28 .

PubMed
Long-term outcome of patients with metastatic breast cancer treated with high-do...
Long-term outcome of patients with metastatic breast cancer treated with high-dose chemotherapy and transplantation of purified autologous hematopoietic stem cells.
Biol Blood Marrow Transplant. 2012 Jan ;18(1):125-33. Epub 2011 Jul 20 .

PubMed
A phase I dose escalation study of TTI-237 in patients with advanced malignant s...
A phase I dose escalation study of TTI-237 in patients with advanced malignant solid tumors.
Invest New Drugs. 2012 Feb ;30(1):266-72. Epub 2010 Aug 10 .

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Display Settings:

Send to:

Classical Clinical Trial Design in Testicular Cancer: Time to Move On.

Source

LinkOut - more resources

Full Text Sources

Supplemental Content

Related citations

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information